Foley Todd — SEC insider filings
SEC reporting owner CIK 1473930. 58 insider filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers the 50 most recent of 58 filings on record, filed 2021-03-16 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 458,629 shares, $8,203,804 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 147 legs across 40 filings — 3,434,101 shares, $75,733,151 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 1,000,000 shares @ $25.10 ($25,100,000) in RHYTHM PHARMACEUTICALS, INC., filed 2021-03-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. (ITOS) | — | 19 | — | 73 legs · 1,535,388 sh · $34,207,377 | 3 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | 1 | — | 1 leg · 1,000,000 sh · $25,100,000 | — |
| Repare Therapeutics Inc. (RPTX) | Director | 15 | — | 49 legs · 338,619 sh · $11,515,796 | 4 |
| Entrada Therapeutics, Inc. (TRDA) | 10% owner | 8 | 1 leg · 100,000 sh · $2,000,000 | 14 legs · 540,669 sh · $4,517,581 | 6 |
| Aktis Oncology, Inc. (AKTS) | Director, 10% owner | 1 | 1 leg · 232,870 sh · $4,191,660 | — | 6 |
| Werewolf Therapeutics, Inc. (HOWL) | 10% owner | 2 | 1 leg · 125,759 sh · $2,012,144 | 1 leg · 1,963 sh · $2,061 | 7 |
| Harpoon Therapeutics, Inc. (HARP) | — | 2 | — | 9 legs · 17,462 sh · $390,336 | — |
| CHIASMA, INC (CHMA) | Director | 1 | — | — | 5 |
| TCR2 THERAPEUTICS INC. (TCRR) | 10% owner | 1 | — | — | 1 |
Insider filings — Foley Todd
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 38,500 @ $7.11 · Sale (S): 192,500 @ $7.41 · Sale (S): 28,837 @ $7.13 | EDGAR |
| 2026-09-03 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 29,088 @ $7.06 · Sale (S): 25,131 @ $7.19 · Sale (S): 32,263 @ $7.17 | EDGAR |
| 2026-08-31 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 38,922 @ $7.20 · Sale (S): 3,733 @ $7.01 · Sale (S): 44,259 @ $6.99 | EDGAR |
| 2026-08-26 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 21,623 @ $7.34 · Sale (S): 26,522 @ $7.54 · Sale (S): 14,569 @ $7.06 | EDGAR |
| 2026-01-14 | 4 | Aktis Oncology, Inc. (AKTS) | Conversion (C): 597,391 · Conversion (C): 2,688,270 · Conversion (C): 716,872 · Purchase (P): 232,870 @ $18 · Conversion (C): 2,272,727 (derivative) @ $0 · Conversion (C): 10,227,273 (derivative) @ $0 · +1 more | EDGAR |
| 2025-05-15 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, EVNIN LUKE | Sale (S): 630,191 @ $8.06 | EDGAR |
| 2025-04-30 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM Asset Management Investors BV2014 LLC | Option exercise/expiry (X): 22,758 @ $0.09 · Sale (S): 1,963 @ $1.05 · Option exercise/expiry (X): 4,015 (derivative) @ $0 · Option exercise/expiry (X): 18,743 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 22,935 @ $20.77 · Sale (S): 21,787 @ $20.23 | EDGAR |
| 2023-06-12 | 4 | Repare Therapeutics Inc. (RPTX) | Grant/award (A): 27,200 (derivative) @ $0 | EDGAR |
| 2023-06-05 | 4 | TCR2 THERAPEUTICS INC. (TCRR) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM ASSET MANAGEMENT LLC | Other (J): 4,158,964 @ $0 | EDGAR |
| 2022-06-06 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 11,918 (derivative) @ $0 | EDGAR |
| 2022-05-16 | 4 | Repare Therapeutics Inc. (RPTX) | Grant/award (A): 49,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 94,745 @ $42.05 · Sale (S): 19,366 @ $43.20 · Sale (S): 6,768 @ $45.32 · Sale (S): 7,671 @ $46.47 · Sale (S): 18,135 @ $42.03 | EDGAR |
| 2021-12-07 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 17,569 @ $34.68 · Sale (S): 2,419 @ $35.44 · Sale (S): 179 @ $36.26 · Sale (S): 8,469 @ $32.35 · Sale (S): 1,171 @ $33.57 · Sale (S): 508 @ $34.08 · +3 more | EDGAR |
| 2021-12-02 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 5,861 @ $34.62 · Sale (S): 28,076 @ $35.19 · Sale (S): 6,042 @ $33.82 · Sale (S): 5,457 @ $34.61 · Sale (S): 896 @ $35.34 · Sale (S): 29,757 @ $33.74 · +1 more | EDGAR |
| 2021-11-30 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 6,545 @ $35.49 · Sale (S): 6,129 @ $36.03 · Sale (S): 10,073 @ $34.46 · Sale (S): 298 @ $35.37 | EDGAR |
| 2021-11-24 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Other (J): 15,671 @ $0 · Sale (S): 9,307 @ $37.16 · Sale (S): 11,807 @ $37.81 · Sale (S): 19,645 @ $36.21 · Sale (S): 359 @ $36.50 · Sale (S): 4,868 @ $35.20 · +2 more | EDGAR |
| 2021-11-04 | 4 | Entrada Therapeutics, Inc. (TRDA) | Conversion (C): 3,816,760 · Conversion (C): 509,024 · Purchase (P): 100,000 @ $20 · Conversion (C): 27,617,675 (derivative) @ $0 · Conversion (C): 3,683,241 (derivative) @ $0 | EDGAR |
| 2021-11-01 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 23,552 (derivative) @ $0 | EDGAR |
| 2021-10-18 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 8,893 @ $27.53 · Sale (S): 2,039 @ $28.01 · Sale (S): 6,167 @ $27.14 | EDGAR |
| 2021-10-14 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 8,521 @ $27.09 · Sale (S): 20,929 @ $27.13 · Sale (S): 27,320 @ $27.30 | EDGAR |
| 2021-10-12 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 1,149 @ $27 · Sale (S): 2,032 @ $27.01 · Sale (S): 48,812 @ $27.24 | EDGAR |
| 2021-10-05 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 6,855 @ $27 · Sale (S): 20,711 @ $27.06 | EDGAR |
| 2021-09-30 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 19,214 @ $27 · Sale (S): 2,292 @ $27 | EDGAR |
| 2021-09-27 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 36,213 @ $27.96 · Sale (S): 717 @ $28.38 · Sale (S): 4,913 @ $27.81 · Sale (S): 11,625 @ $27.09 | EDGAR |
| 2021-09-23 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 19,635 @ $27.47 · Sale (S): 14,294 @ $27.54 | EDGAR |
| 2021-09-20 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 21,253 @ $28.47 · Sale (S): 45,698 @ $28.82 · Sale (S): 10,602 @ $27.03 · Sale (S): 13,701 @ $27.84 | EDGAR |
| 2021-09-16 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 17,938 @ $27.50 · Sale (S): 3,623 @ $27.99 · Sale (S): 23,113 @ $27.79 · Sale (S): 991 @ $28.15 | EDGAR |
| 2021-09-13 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 22,725 @ $28.97 · Sale (S): 6,760 @ $27.86 · Sale (S): 6,771 @ $28.73 · Sale (S): 21,384 @ $27.64 | EDGAR |
| 2021-09-08 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 30,474 @ $29.18 · Other (J): 31,340 @ $0 · Sale (S): 11,152 @ $28.61 · Sale (S): 940 @ $29.10 | EDGAR |
| 2021-08-05 | 4 | CHIASMA, INC (CHMA) | Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 13,000 (derivative) @ $0 · Disposition to issuer (D): 13,000 (derivative) @ $0 · Disposition to issuer (D): 13,000 (derivative) @ $0 · Disposition to issuer (D): 13,000 (derivative) @ $0 | EDGAR |
| 2021-07-13 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 1,792 @ $33.06 · Sale (S): 25,246 @ $33.58 · Sale (S): 313 @ $34.10 | EDGAR |
| 2021-06-30 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 6,080 @ $34.06 · Sale (S): 1,190 @ $34.82 · Sale (S): 1,190 @ $33.29 | EDGAR |
| 2021-06-28 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 2,697 @ $33.53 · Sale (S): 9,943 @ $33.51 | EDGAR |
| 2021-06-23 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 2,556 @ $33.80 · Sale (S): 14,006 @ $34.63 · Sale (S): 1,486 @ $33.36 · Sale (S): 189 @ $34.09 · Sale (S): 622 @ $32.98 | EDGAR |
| 2021-06-21 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 13,575 @ $33.78 · Sale (S): 753 @ $34.12 · Sale (S): 2,556 @ $33.46 · Sale (S): 1,410 @ $34.03 | EDGAR |
| 2021-06-16 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 881 @ $33.09 · Sale (S): 1,862 @ $33.33 | EDGAR |
| 2021-06-10 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 3,985 @ $32.80 · Sale (S): 7,559 @ $33.41 · Sale (S): 4,785 @ $34.42 · Sale (S): 10,738 @ $34.79 | EDGAR |
| 2021-06-07 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 9,824 @ $31.92 · Sale (S): 3,544 @ $30.80 · Sale (S): 2,068 @ $31.28 · Sale (S): 1,058 @ $30.74 · Sale (S): 749 @ $32.25 · Sale (S): 8,379 @ $32.96 | EDGAR |
| 2021-06-02 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 7,377 @ $32.67 · Sale (S): 6,671 @ $32.50 · Sale (S): 2,608 @ $31.83 · Sale (S): 130 @ $32.42 | EDGAR |
| 2021-05-27 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 2,852 @ $32.87 · Sale (S): 44 @ $33.59 · Sale (S): 9,839 @ $32.74 · Sale (S): 751 @ $33.01 · Sale (S): 1,906 @ $32.81 · Sale (S): 1,597 @ $33.16 | EDGAR |
| 2021-05-24 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 133,359 @ $34.80 · Sale (S): 1,563 @ $33.30 · Sale (S): 8,219 @ $34.28 | EDGAR |
| 2021-05-20 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 6,509 @ $33.90 · Sale (S): 3,763 @ $34.61 · Sale (S): 40 @ $35.14 · Other (J): 21,834 @ $0 · Sale (S): 4,029 @ $34.23 · Sale (S): 1,939 @ $35 · +2 more | EDGAR |
| 2021-05-14 | 4 | Repare Therapeutics Inc. (RPTX) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2021-05-06 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM Asset Management Investors BV2014 LLC | Conversion (C): 2,298,430 · Conversion (C): 763,809 · Purchase (P): 125,759 @ $16 · Conversion (C): 19,925,321 (derivative) @ $0 · Conversion (C): 6,621,546 (derivative) @ $0 | EDGAR |
| 2021-04-15 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, EVNIN LUKE | Sale (S): 1,657 @ $19.35 · Sale (S): 286 @ $20.08 · Sale (S): 121 @ $20.06 · Sale (S): 1,550 @ $20.83 · Sale (S): 1,052 @ $20.49 | EDGAR |
| 2021-04-13 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, EVNIN LUKE | Sale (S): 10,300 @ $23.67 · Sale (S): 1,637 @ $20.72 · Sale (S): 811 @ $21.52 · Sale (S): 48 @ $22.68 | EDGAR |
| 2021-04-13 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 119 @ $29.99 | EDGAR |
| 2021-04-09 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 3,164 @ $32.07 · Sale (S): 1,842 @ $32.84 · Sale (S): 777 @ $33.84 · Other (J): 15,670 @ $0 · Sale (S): 19,057 @ $30.51 · Sale (S): 247 @ $31.01 | EDGAR |
| 2021-03-16 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 1,000,000 @ $25.10 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1473930 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs